Skip to content
OpenCapital
Get started

Pediatrix Medical Group MD Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Inter Parfums logo
Inter ParfumsIPAR
$158.09M+26.0%
MarketAxess logo
MarketAxessMKTX
$548.24M-14.9%
SM Energy logo
SM EnergySM
$449M—
Celcuity logo
CelcuityCELC
$145.19M+781%
BGC Group, Inc. logo
BGC Group, Inc.BGC
$803.1M-18.5%
UMH
UMH PropertiesUMH
$45.97M-1.1%

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×—
P/S1×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive)?
Pediatrix Medical Group (MD) reported total cash, cash equivalents, and restricted cash (inclusive) of $205.78M in Q1 2026.
How has Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive) increased by 107.9% year-over-year, from $98.98M to $205.78M.
What is the long-term trend for Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive)?
Over 5 years (2020 to 2025), Pediatrix Medical Group's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -19.7% compound annual growth rate (CAGR), from $1.12B to $375.24M.